DENTSPLY SIRONA (XRAY) Beats On Q3 Earnings, Ups '19 View

Zacks Investment Research | Nov 06, 2019 10:28PM ET

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) reported adjusted earnings per share (EPS) of 57 cents in the third quarter of 2019, beating the Zacks Consensus Estimate of 50 cents. The bottom line surged 51.4% from the prior-year quarter’s figure.

The Zacks Rank #2 (Buy) company’s revenues rose 3.6% year over year to $962.1 million and outpaced the Zacks Consensus Estimate of $944.9 million. Per management, internal sales growth was 7.5%.

Business Details

Net sales Excluding Precious Metal Content

Net sales, excluding precious metal content, came in at $950.6 million. The figure increased 3.3% on a year-over-year basis.

For investors’ notice, DENTSPLY SIRONA’s precious-metal dental alloy products — used by third parties to construct crown and bridge materials — are subject to price fluctuations.

Technology & Equipment

Per management, Technology & Equipment revenues rose 5.1% year over year in the third quarter to $534.5 million. Per management, growth came on the back of Digital Dentistry and Healthcare, offset partially by weakness in Equipment & Instruments sales and competitive pressures in Imaging business.

Consumables

DENTSPLY SIRONA Consumable revenues rose 1.8% year over year to $427.6 million in the reported quarter. Per management, the upside was driven by growth in sales of Restorative and Endodontics products.

Revenues by Geography

In the United States, revenues moved up 2.5% to $337 million and 4% internally. Rest of World revenues increased 5.1% year over year to $263.7 million. Revenues in the geography grew 10% on an internal sales growth basis. European revenues climbed 3.6% year on year to $361.4 million. On an internal sales growth basis, European revenues increased 8.4%.

DENTSPLY SIRONA Inc. Price, Consensus and EPS Surprise

Get The News You Want

Read market moving news with a personalized feed of stocks you care about.

Get The App

Get The News You Want

Read market moving news with a personalized feed of stocks you care about.

Get The App

Original post

Written By: Zacks Investment Research

Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

Show moreShow Less